Filippo Giovanardi

492 total citations
14 papers, 132 citations indexed

About

Filippo Giovanardi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Filippo Giovanardi has authored 14 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Filippo Giovanardi's work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). Filippo Giovanardi is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and Advanced Breast Cancer Therapies (3 papers). Filippo Giovanardi collaborates with scholars based in Italy. Filippo Giovanardi's co-authors include Paolo Veronesi, Giuseppe Viale, Andrea Rocca, Marco Colleoni, Alberto Luini, R. Ghisini, Rosalba Torrisi, Alessandra Balduzzi, Laura Orlando and Luca Bottiglieri and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CHEST Journal.

In The Last Decade

Filippo Giovanardi

12 papers receiving 128 citations

Peers

Filippo Giovanardi

ONCOL

PRM

RHEUM

Elisabeth Melbinger‐Zeinitzer Austria

Zhigang Han China

Ricardo Brugés Colombia

Alicia‐Marie Conway United Kingdom

Catherine Becht France

Jorge S. Reis-Filho United States

David Dum Germany

Hwei-Chung Wang Taiwan

T. Tuziak Poland

Damien Vasseur France

Elisabeth Melbinger‐Zeinitzer Austria

Filippo Giovanardi

179 ×2.1

ONCOL

62 ×0.8

40 ×1.1

PRM

64 ×3.4

10 ×0.5

RHEUM

Citations per year, relative to Filippo Giovanardi Filippo Giovanardi (= 1×) peers Elisabeth Melbinger‐Zeinitzer

Countries citing papers authored by Filippo Giovanardi

Since Specialization

Citations

This map shows the geographic impact of Filippo Giovanardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Giovanardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Giovanardi more than expected).

Fields of papers citing papers by Filippo Giovanardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Giovanardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Giovanardi. The network helps show where Filippo Giovanardi may publish in the future.

Co-authorship network of co-authors of Filippo Giovanardi

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Giovanardi. A scholar is included among the top collaborators of Filippo Giovanardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Giovanardi. Filippo Giovanardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Meregaglia, Michela, Chiara Bennati, Filippo Giovanardi, et al.. (2024). MA14.13 Analysis of Lung Cancer-Specific Patient-Reported Outcome Measures (PROMs): Results from the PRO4All Project. Journal of Thoracic Oncology. 19(10). S115–S116.

Giovanardi, Filippo, Roberto Di Cicilia, Alessandra Bologna, et al.. (2024). Systemic inflammatory markers in neoadjuvant pembrolizumab therapy for triple-negative breast cancer: Prognostic insights and nomogram construction.. Journal of Clinical Oncology. 42(16_suppl). e12649–e12649. 2 indexed citations

Giovanardi, Filippo, Michela Meregaglia, Alberto Servetto, et al.. (2024). Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project. The Breast. 78. 103817–103817. 1 indexed citations

Giovanardi, Filippo, Edoardo Carretto, Giancarlo Bisagni, et al.. (2023). Abstract P3-03-04: Cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer during the COVID pandemic period: efficacy in relation to vaccination for SARS-COV 19. Cancer Research. 83(5_Supplement). P3–3.

Toss, Angela, Elena Tenedini, Alessandra Bologna, et al.. (2021). The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study. Diagnostics. 11(3). 565–565. 5 indexed citations

Brandi, Giovanni, Giuseppe Di Pasquale, P. De Carolis, et al.. (2021). Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology. BMJ Open. 11(5). e043239–e043239. 5 indexed citations

Lambertini, Matteo, Valentina Guarneri, Andrea Rocca, et al.. (2020). 95TiP Gruppo Italiano Mammella (GIM) 10 – CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR+) early breast cancer (EBC). Annals of Oncology. 31. S47–S47. 1 indexed citations

Vicentini, Massimo, et al.. (2015). Axillary Nodal Metastases in Italian Early Breast Cancer Patients with Positive Sentinel Lymph Node: Can Axillary Node Dissection be Avoided by using Predictive Nomograms?. Tumori Journal. 101(3). 298–305. 7 indexed citations

Gennari, Alessandra, Oriana Nanni, Andrea DeCensi, et al.. (2015). Abstract P3-13-02: Phase II randomised clinical study of first line chemotherapy plus metformin versus first line chemotherapy alone in HER2 negative, non diabetic, metastatic breast cancer patients: Final results of the MYME study. Cancer Research. 75(9_Supplement). P3–13. 1 indexed citations

10.

Cazzaniga, Marina Elena, Valter Torri, Laura Cortesi, et al.. (2015). PO64 METRONOMIC CHEMOTHERAPY (CHT) COMBINATION OF VINORELBINE (VRL) AND CAPECITABINE (CAPE) IN HER2- ADVANCED BREAST CANCER (ABC) PATIENTS (PTS) DOES NOT IMPAIR GLOBAL QOL. FIRST RESULTS OF THE VICTOR-2 STUDY. The Breast. 24. S44–S44. 1 indexed citations

11.

Giovanardi, Filippo, et al.. (2013). Increased Mean Corpuscular Volume of Red Blood Cells in Patients Treated with Capecitabine for Advanced Breast and Colon Cancer. Chemotherapy. 59(5). 369–372. 4 indexed citations

12.

Torrisi, Rosalba, Alessandra Balduzzi, R. Ghisini, et al.. (2007). Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. Cancer Chemotherapy and Pharmacology. 62(4). 667–672. 75 indexed citations

13.

Rocca, Andrea, G. Peruzzotti, R. Ghisini, et al.. (2006). A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer. Anti-Cancer Drugs. 17(10). 1201–1209. 9 indexed citations

14.

Rossi, Giulio, Laura Schirosi, Filippo Giovanardi, et al.. (2006). Pleural Malignant Solitary Fibrous Tumor With Sarcomatous Overgrowth Showing PDGFR β Mutation. CHEST Journal. 130(2). 581–583. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact